These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26858375)

  • 41. Addressing supply side barriers to introduction of new vaccines to the developing world.
    McElligott S
    Am J Law Med; 2009; 35(2-3):415-41. PubMed ID: 19697757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The hidden cost of low prices: limited access to new drugs in India.
    Berndt ER; Cockburn IM
    Health Aff (Millwood); 2014 Sep; 33(9):1567-75. PubMed ID: 25201661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BARDA funds vaccine makers aiming to phase out eggs.
    Strauss S
    Nat Biotechnol; 2010 Dec; 28(12):1227-8. PubMed ID: 21139593
    [No Abstract]   [Full Text] [Related]  

  • 44. Public health. U.S. vaccine supply falls seriously short.
    Cohen J
    Science; 2002 Mar; 295(5562):1998-2001. PubMed ID: 11896251
    [No Abstract]   [Full Text] [Related]  

  • 45. Vaccine shortages: why they occur and what needs to be done to strengthen vaccine supply.
    Klein JO; Myers MG
    Pediatrics; 2006 Jun; 117(6):2269-75. PubMed ID: 16740872
    [No Abstract]   [Full Text] [Related]  

  • 46. Drug and vaccine development for infectious diseases: the value of priority review vouchers.
    Matheny J; Smith B; Courtney B; Mair M
    Clin Pharmacol Ther; 2009 Jun; 85(6):571-2. PubMed ID: 19451907
    [No Abstract]   [Full Text] [Related]  

  • 47. Thirty Years of Media Coverage on High Drug Prices in the United States--A Never-Ending Story or a Time for Change?
    Leopold C; Chambers JD; Wagner AK
    Value Health; 2016 Jan; 19(1):14-6. PubMed ID: 26797230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness.
    Berndt ER; Glennerster R; Kremer MR; Lee J; Levine R; Weizsäcker G; Williams H
    Health Econ; 2007 May; 16(5):491-511. PubMed ID: 17013993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study.
    Yang C; Wu L; Cai W; Zhu W; Shen Q; Li Z; Fang Y
    PLoS One; 2016; 11(10):e0165183. PubMed ID: 27780218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug shortages: a complex health care crisis.
    Fox ER; Sweet BV; Jensen V
    Mayo Clin Proc; 2014 Mar; 89(3):361-73. PubMed ID: 24582195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Size of clinical trials and Introductory prices of prophylactic vaccine series.
    Weinberg SH; Butchart AT; Davis MM
    Hum Vaccin Immunother; 2012 Aug; 8(8):1066-70. PubMed ID: 22854668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pediatricians' adherence to pneumococcal conjugate vaccine shortage recommendations in 2 national shortages.
    Fairbrother G; Broder K; Staat MA; Schwartz B; Heubi C; Hiratzka S; Walker FJ; Morrow AL
    Pediatrics; 2007 Aug; 120(2):e401-9. PubMed ID: 17646354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. USA faces chronic vaccine shortages.
    Nelson R
    Lancet Infect Dis; 2004 Feb; 4(2):66. PubMed ID: 14959757
    [No Abstract]   [Full Text] [Related]  

  • 54. U.S. childhood vaccine availability: legal, regulatory, and economic complexities.
    Strongin RJ
    NHPF Issue Brief; 2002 Nov; (785):1-20. PubMed ID: 12463233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug shortages: the cycle of quantity and quality.
    Kweder SL; Dill S
    Clin Pharmacol Ther; 2013 Mar; 93(3):245-51. PubMed ID: 23340474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention.
    Rodewald LE; Orenstein WA; Mason DD; Cochi SL
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S104-10. PubMed ID: 16447130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccine purchasing groups in the United States: An overview of their policies and practices.
    Cowan AE; Clark SJ; Gordon JL; Bok K; Shen AK
    Vaccine; 2016 Sep; 34(42):5060-5065. PubMed ID: 27614782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Millennium mergers bring pipeline.
    Dove A
    Nat Biotechnol; 1999 Dec; 17(12):1151. PubMed ID: 10585700
    [No Abstract]   [Full Text] [Related]  

  • 59. Impact of Drug Shortages on Health System Pharmacies in the Southeastern United States.
    Caulder CR; Mehta B; Bookstaver PB; Sims LD; Stevenson B
    Hosp Pharm; 2015 Apr; 50(4):279-86. PubMed ID: 26448658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Shortage of Peritoneal Dialysis Solution and the Food and Drug Administration's Response.
    Jensen V; Throckmorton DC
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1484-6. PubMed ID: 25896999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.